Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE inhibition and skeletal muscle weakness in COPD
2008-004431-38Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of fosinopril in chronic obstructive pulmonary disease (COPD), sponsored by Imperial College London. Primary endpoint: IGF-1/AKT pathway activity in skeletal muscle. Started Nov 2010; status: completed.
02
Drugs
fosinopril
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-004431-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004431-38.